Milnacipran and Special Patient Profiles Suicidal risk Less suicide attempts and completed suicides 107 Montgomery SA. The place of milnacipran in cli
{"Image DocumentName": "Patients exposure years (n)", "Image ImageDescription": "Milnacipran and Special Patient Profiles. Suicidal risk. Less suicide attempts and completed suicides. Suicide attempts. Completed suicides. Patients exposure years (n) [log scale] Placebo. TCAs. SSRIs. Milnacipran. Treatment. Absolute number of suicides and suicide attempts in patients treated with milnacipran are low. The incidence of suicide attempts is of about 4.9 cases per 100 patient exposure years, slightly less than with TCAs and markedly less than in patients treated with SSRIs or in placebo-treated patients (respectively 20 and 16 cases/100 patient exposure years). In terms of the actual number of completed suicides, rates in milnacipran treated patients were approximately 3 times lower than in patients on placebo. Montgomery SA. The place of milnacipran in clinical practice. Int Clin Psychopharmacol 2003;18(Suppl 1):S1-S", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}